BlueOcean NutraSciences Inc. Buys 100% of Pure Polar Joint Venture and Issues Options
December 20, 2016 (Source) — BlueOcean NutraSciences Inc. (TSXV:BOC) (“BlueOcean” or the “Company”) announces that effective December 9, 2016, BlueOcean has terminated the joint venture with Pure Polar Labs Inc. (“Pure Polar”) and has purchased all of the issued and outstanding shares. As of December 9, 2016, Pure Polar has become a wholly-owned subsidiary of BlueOcean.
The Company also announces that the Board of Directors has approved as of December 19, 2016, the issuance of 15,000 stock options (the “Options”) to eligible participants of the Company’s stock option plan (the “Plan”). All Options vested immediately on issuance and are exercisable into common shares of the Company at an exercise price of $0.15 over the next 2 years, all in accordance with the Plan.
BlueOcean NutraSciences Inc. is a Canadian listed public Company that is focused on developing sustainable, specialty nutraceutical oil products targeted at the rapidly growing Natural Astaxanthin, Omega-3 and Algal oil health and wellness markets. BlueOcean’s bulk shrimp oils contain high levels of naturally occurring astaxanthin, phospholipids, and omega-3 EPA and DHA. Northern and Pacific AstaShrimp(TM) bulk oils are targeted at the high value and rapidly growing natural astaxanthin and phospholipid omega-3 markets.
BlueOcean’s Pure Polar(TM) Omega-3 Shrimp Oil formulations contain over two times more omega-3 EPA & DHA and 10 times more astaxanthin than typical retail krill oil brands, and contain phospholipids for better absorption of omega-3s. Product details and ordering can be found at:
www.purepolarshrimp.com, Amazon.com, Inboxfitness.com and LuckyVitamin.com
Get our daily investorintel update
This news release may contain forward-looking statements that are based on BlueOcean’s expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
InvestorIntel is a trusted source of reliable information at the forefront of emerging markets that brings investment opportunities to discerning investors.